Health AI Central
Peer-Reviewed Publication
Drug Discov Today2025;30(8):104423.August 1, 2025Editorial

Experts hail regulatory impact assessment as ripe for GenAI transformation, to streamline product change control.

Agnes Cwienczek1
1Director of Product Management ArisGlobal, Radnička cesta 47, 10000 Zagreb, Croatia. Electronic address: acwienczek@arisglobal.com.
PubMed DOI

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.